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A sheep liver cDNA clone for the cytosolic serine hydroxymethyltransferase (SHMT) was isolated 
and its nucleotide sequence determined. The full-length cDNA of SHMT was placed under the control 
of T7 promoter in PET-3C plasmid and expressed in Escherichia coli. The overexpressed enzyme, present 
predominantly in the soluble fraction, was catalytically active. The recombinant SHMT was purified to 
homogeneity with a yield of 10 mg/l bacterial culture. The recombinant enzyme was capable of carrying 
out tetrahydrofolate-dependent and tetrahydrofolate-independent reactions as effectively as the native 
enzyme. The K,,, values for serine (1 mM) and tetrahydrofolate (0.82 mM) were similar to those of the 
native enzyme. The recombinant enzyme had a characteristic visible spectrum indicative of the presence 
of pyridoxal 5’-phosphate as an internal aldimine. The apoenzyme obtained upon removal of the cofactor 
was inactive and could be reconstituted by the addition of pyridoxal 5‘-phosphate demonstrating that the 
recombinant SHMT was functionally very similar to the native SHMT. This overexpression of eukaryotic 
tetrameric SHMT in E. coli and the purification and characterization of the recombinant enzyme should 
thus allow studies on the role of specific amino acids and domains in the activity of the enzyme. 
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Serine hydroxymethyltransferase (SHMT) is a pyridoxal-5’- 
phosphate(pyrid0xal-P)-dependent enzyme catalyzing the re- 
versible conversion of serine and tetrahydrofolate (H,-folate) to 
glycine and 5,10-methylene-H4-folate. This enzyme is a compo- 
nent of thymidylate cycle, along with thymidylate synthase and 
dihydrofolate reductase. The latter two enzymes are not only 
targets for cancer chemotherapy but also have served as model 
systems to study the stmcture/function relationships. 
Earlier studies from our laboratory on the mechanism of in- 
teraction of substrates and substrate analogues with sheep liver 
SHMT has led to the design of active-site-directed inhibitors of 
SHMT [I -51. The chemical modification studies with the sheep 
liver enzyme, indicated that histidine, cysteine and arginine resi- 
dues were essential for activity [6], and the involvement of 
Arg269 in the binding of H,-folate was demonstrated [7] .  In 
spite of the successful isolation of the gene from several eukary- 
otic systems [8-121, the overexpression of this gene has not 
been reported. However, for understanding the structure/function 
relationship of the enzyme, it would be necessary to have an 
overexpressing clone of SHMT. In this communication, cloning, 
sequencing, and overexpression of the cytosolic sheep liver 
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SHMT gene in E. coli is reported. We also describe the purifica- 
tion and characterization of the recombinant SHMT. 
EXPERIMENTAL PROCEDURES 
Materials. [a-”P]dATP (3000 Ci/mmol), [a-3ZP]dCTP 
(3000 Ci/mmol) were obtained from Board of Radiation and 
Isotope Technology, Unit of Department of Atomic Energy, 
Government of India, Bombay, India. [35S]dATP[a-S] (600 Cil 
mmol), ~-[3-’~C]serine (55 mCi/mmol), were obtained from 
Amersham International. Restriction endonucleases, DNA- 
modifying enzymes were purchased from New England Biolabs, 
Perkin-Elmer Cetus and Amersham International. Cibacron 
Blue-agarose was from Bethesda Research Laboratories. CM- 
Sephadex C-50, Sephacryl S-200 were obtained from Pharmacia 
Fine Chemicals. All other biochemicals used in this study were 
obtained from Sigma Chemical Company. H,-Folate was pre- 
pared by the method of Hatefi et al. [13]. Sheep liver cDNA 
S’stretch (SWAJ-2) library was purchased from Clonetech 
Laboratories, Inc. The oligonucleotide primers were synthesized 
by Oligonucleotide Synthesis Facility, Centre for Genetic 
Engineering, Indian Institute of Science, Bangalore, India and 
National Biosciences, Plymouth MN, USA. 
Bacterial strains and growth conditions. E. coli strain 
DH5a (Bethesda Research Laboratories) was the recipient for 
the plasmids used in subcloning and sequencing. Strain LE392 
(obtained from Clonetech laboratories) was the recipient strain 
for plating the phage. BL21(DE3) 1141 strain was used for the 
bacterial expression of PET-SHMT construct. 
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E. coli strains containing the plasmids were grown in Luria- 
Bertani medium or in terrific broth as described by Sambrook 
et al. 1151. 
Plasmid and ADNA isolation, DNA modifications and 
bacterial transformation. Plasmid preparations were by the 
alkaline lysis procedure as described by Sambrook et al. [15]. 
ADNA was isolated by the plate lysate method [15] with the 
following modifications. Before poly(ethy1ene glycol) precipita- 
tion, the phage was passed through a DEAE-cellulose column. 
DNA from the phage particles was released upon proteinase-K 
treatment. Restriction endonuclease digestions, nuclease diges- 
tions and ligations were carried out according to the manufactur- 
er's instructions. The preparation of competent cells and trans- 
formation were carried out by the method of Alexander et al. 
I161. 
PCR amplification of SHMT gene-specific cDNA frag- 
ment. Based on the amino acid sequence of sheep cytosolic 
SHMT determined by Usha et al. [17], two degenerate oligonu- 
cleotides DSHI (5'-CAGAGRGTSGGSCTSGAGCTSATCG- 
CYAGCGAGAACTT-3') and DSH2 (5'-GCCYCTSAGGG- 
TYTTRTGGGTGGTGGTGGTSACSACRTG-3') were synthe- 
sized. The degenerate positions are indicated by R for purines, 
Y for pyrimidines, and S for G or C. PCR amplification was 
performed using AmpliTaq (Perkin-Elmer Cetus) as described in 
Perkin-Elmer Cetus protocol for DNA amplification with the 
following modifications. ADNA (0.1 pg) isolated from the pool 
of a sheep liver cDNA library and the oligonucleotides DSHI 
and DSH2 (1 pM each) were added to a 20 pl reaction mixture. 
The samples were incubated in a thermal cycler for 30 cycles 
with 1 min denaturation (94"C), 1 min annealing (55 "C), and 2- 
min chain elongation (72°C). After 30 cycles, the reaction was 
continued for another 10-min elongation at 72°C. The PCR 
product was gel purified using Geneclean 11 kit (BIO-101). 
Using EcoRV-digested pBlueseript (Stratagene), T-vector was 
prepared by the method of Marchauk et al. [18]. The PCR prod- 
uct was cloned into this T-vector and designated as pPSH. 
Isolation of a sheep liver SHMT cDNA clone. Plaques 
were transferred to Duralon-UVm membranes (Stratagene) and 
the DNA was fixed to the membrane by ultraviolet cross-linking. 
The PCR product was random-primer labeled by the method of 
Feinberg and Vogelstein [19] and purified through the Sephadex 
G-50 spun column as described by Sambrook et al. [15]. The 
membranes were washed as described by Sambrook et al. [15]. 
The prehybridization (with 50% formamide, 10% dextran sul- 
fate, 1 % SDS, 0.9 M NaCl and 200 pg of salmon sperm DNA), 
hybridization (denatured probe at 500 000 c p d m l  prehybridiza- 
tion solution) and posthybridization [with 0.1 XNaCVCit (NaCl/ 
Cit, 0.15 M NaCl, 15 mM sodium citrate, pH 7), 0.1 % SDS at 
65"C] conditions used were as described in the Stratagene in- 
struction manual for Duralon-UVTM membranes. 
ExonucleaseIIYSl nuclease deletions and DNA sequenc- 
ing. For deletions, supercoiled plasmid was prepared by the 
method of Wang et al. 1201. Deletions were performed using 
ExoIII/Sl nuclease as described in the Promega protocols and 
applications guide. DNA sequencing was performed by Sanger 's 
dideoxynucleotide chain-termination method [21] using Circum- 
VentTM thermal cycle sequencing kit (New England Biolabs). 
Construction of PET-SHMT. SHPl (sense oligonucleo- 
tide), with one extra T addition at the S'terminus of the oligonu- 
cleotide (5'-TATGGCAGCTCCAGTCAAC-3') and SHMl (anti- 
sense olignucleotide) with a TA addition at the 5' terminus 
of the oligonucleotide (5'-TATCTAGAAGCCAGGCAGG-3') 
spanning the start and stop codons, respectively, were synthe- 
sized. PCR was performed using Vent DNA polymerase as de- 
scribed in New England Biolabs product specifications with the 
following modifications. For a 100-pl reaction, 6 ng of the full- 
length sheep SHMT cDNA clone (pSH11) DNA, 0.16 pM of 
each primer and 0.4 mM of each dNTP were used. The sample 
was incubated in a thermal cycler at 94°C for 4 min, then kept 
for 25 cycles of amplification. Each cycle included 1 min dena- 
turation (94"C), 1 min annealing (50"C), and 1.5 rnin chain 
elongation (72°C). After 25 cycles, the reaction was extended 
for an additional 5 min at 72°C. The 1.45-kb PCR product was 
purified from the agarose gel using Geneclean I1 kit. 
NdeI-compatible ends were generated at the 5' and 3' ends 
of 1.45-kb Vent polymerase PCR product using the dinucleotide 
and trinucleotide sticky-end cloning (DISEC-TFUSEC) method 
of Dietmaier et al. [22] with some modifications. The PCR prod- 
uct was treated with T4 DNA polymerase in the presence of 
0.2 mM each of dGTP, dCTP for 30 min at 12"C, then dATP 
was added to 0.2 mM concentration and incubated for 10 rnin at 
37 "C. After performing reactions as above, DNA was extracted 
with phenol/chloroform and kept for alcohol precipitation. This 
DNA fragment was cloned at the NdeI site of PET-3C plasmid 
1231. The presence of the insert in the proper orientation with 
respect to the T7 promoter was confirmed by sequencing. 
The expression of SHMT in E. coli BL21 (DE3) and puri- 
fication of the recombinant SHMT. E. coli BL21 (DE3) strain 
cells harboring the PET-SHMT plasmid were grown in 1 1 Luria- 
Bertani medium containing 50 pg/ml ampicillin and 0.2% glu- 
cose. After absorbance at 600 nm reached 0.8, isopropyl-l-thio- 
P-D-galactopyranoside (0.4 mM) was added to induce the en- 
zyme. 2 h later, the cells were harvested and the cell pellet was 
resuspended in 100 ml buffer A (50 mM sodium phosphate, 
pH 7.4, containing 2 mM EDTA, 1 mM m-dithiothreitol and 
100 pM pyridoxal-P) and frozen at -20°C for overnight. To the 
thawed cells, 5 mg lysozyme and 1 mM phenylmethylsuifonyl 
fluoride were added and incubated at room temperature for 
30 min. The cell suspension was sonicated until it became 
optically clear. The sonicate was centrifuged at 27000Xg for 
30 min. The supernatant was made up to 25% ammonium sul- 
fate saturation and the precipitate was discarded. The superna- 
tant was raised to 65% ammonium sulfate saturation by the ad- 
dition of solid ammonium sulfate. The pellet obtained after the 
second ammonium sulfate fractionation was dissolved in 20 ml 
buffer B (20 mM sodium phosphate pH 7.4, containing 1 mM 
2-mercaptoethanol, 1 mM EDTA and 50 pM pyridoxal-P) and 
dialyzed against the same buffer (21 with two changes). The 
dialyzed ammonium sulfate extract was loaded on to a Cibacron 
Blue agarose column (1.75 cmX12 cm). The column was 
washed with 200ml buffer C (50mM sodium phosphate, 
pH 7.4, containing 1 mM 2-mercaptoethanol, 1 mM EDTA and 
50 pM pyridoxal-P) and the enzyme was eluted with a 0 to 1-M 
KCl gradient in buffer C. 2-ml fractions were collected and 
active fractions were pooled (25 ml). The Cibacron Blue agarose 
eluant was concentrated by 0-65 % ammonium sulfate precipi- 
tation and the precipitate was dissolved in 5 ml buffer C, loaded 
onto a Sephacryl S-200 column (3.0 cmXlOO cm previously 
equilibrated with the buffer D (200 mM sodium phosphate, 
pH 7.4, containing 1 mM 2-mercaptoethanol, 1 mM EDTA and 
50 pM pyridoxal-P) and 6-ml fractions were collected. The 
active fractions were pooled (45 ml), concentrated to 1.6 ml and 
used as the source of the enzyme in further characterization of 
the recombinant SHMT. 
The recombinant apoenzyme was prepared from the holoen- 
zyme using D-alanine as the substrate [24]. 
Native sheep liver SHMT was purified as described by Bask- 
aran et al. [2]. 
SHMT was assayed using [3-'4C]serine and H,-folate as sub- 
strates [25, 261. Protein was estimated using BSA as a standard 
1271. 
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Protein sequencing. The recombinant SHMT was analyzed 
on SDS/PAGE [28], transferred to ImmobilonTM-P membrane 
(Millipore), stained with Ponceau-S and the appropriate band 
was cut out. The cut membrane containing the protein was 
destained and loaded on to a Shimadzu gas-phase sequenator, 
PSQ-1 [29]. 
RESULTS 
Isolation of a cDNA clone for sheep liver SHMT. A cDNA 
fragment of 0.65 kb was amplified by PCR using primers DSHl 
and DSH2. DSHl has a partly degenerate sequence coding for 
the amino acids, QRVGLELIASENF, residues 43-55 in the 
sheep liver cytosolic SHMT [17], while DSH2 is also partly 
degenerate, codes for HVVTTTTHKTLRG, residues 248 - 260 
of the sheep liver SHMT. The PCR product was cloned in T- 
pBluescript KS( +) vector. Plasmid (pPSH) containing the insert 
was identified and sequenced from both the ends. The predicted 
amino acid sequence encoded by insert DNA was homologous 
to the sheep cytosolic SHMT amino acid sequence [17]. The 
sheep liver cDNA library (70000 plaques) was screened using 
the 650-bp PCR product and 10 positive clones were identified 
after three successive rounds of screening. The maximum size 
of the insert from all these clones was only 1.2 kb instead of the 
expected 1.45 kb for the full-length clone. The pPSH contained 
additional 135 bp at the 5’ end compared to the 1.2-kb partial 
clones. This 135-bp fragment was used to screen the cDNA li- 
brary (300000 plaques) to identify full-length clones. 12 positive 
clones were identified after four successive rounds of screening 
and the inserts from these positive clones were in the range of 
1.3- 1.7 kb. 
Subcloning and sequencing. The inserts were released from the 
A clones by partial EcoRI and complete XbaI digestion and 
cloned in pBluescript at EcaRI and XbaI sites. The plasmid 
clones with inserts of more than 1.2 kb were selected. The 
clones pSHl, pSH2 and pSH8 of 1.5 kb and pSHll (1.7 kb) 
were used for further characterization. ExoIIIIS1 nuclease dele- 
tions were performed using pSHl1 in both directions and all the 
deletion clones were sequenced. pSHl1 has an open reading 
frame (ORF) with 1452 bp and 198 bp 5’ non-coding sequence 
in which the most 5’ 172 bp were identical with the actin gene. 
This is probably a cloning artifact produced during the prepara- 
tion of the cDNA library. However sequencing of the 5’ and 3’ 
ends of pSHl and pSH8 clones showed the presence of a 1452- 
bp ORF and a 20-bp 5’ non-coding sequence, whereas, the pSH2 
clone indicated the presence of a 26-bp non-coding sequence in 
addition to OW. Sheep cDNA library was constructed by clon- 
ing the cDNA at EcoRI and Xbal sites of ASWAJ-2 vector with- 
out protecting the internal XbaI sites. Due to the presence of an 
internal XbaI site at the stop codon, none of the clones contained 
the 3’ non-coding sequence. The complete nucleotide sequence 
of sheep cytosolic SHMT obtained from pSHll is shown in 
Fig. 1. The deduced amino acid sequence showed 98% identity 
with sheep liver cytosolic SHMT sequence [17], 90.5% identity 
with rabbit [lo, 301 and human [ l l ]  SHMT. 
Overexpression of sheep SHMT. The cDNA encoding SHMT, 
from Met1 through the TAG stop codon, was placed under the 
control of a strong T7 promoter (for details, see Experimental 
Procedures and Fig. 2). To avoid errors in the PCR amplifica- 
tion, we have used Vent DNA polymerase which, has a 5-15- 
fold more efficient proof-reading activity compared with Taq 
polymerase [31, 321. The bacterial cells containing the SHMT 
expression plasmid (PET-SHMT) were induced with isopropyl- 
GGATCGGGTGCCTCTGAACCAGCACAATGGCAGCTCCAGTCAACAAGGCACCCAGAGATG 
M A A P V N K A P R V A  
CCGATTTGTGGTCCTTGCATGAGAAGATGCTGGCACAGCCCCTGAAGGACAACGATGTCG 
V L W S L H E X M L A Q P L K D N D V E  
AGGTTTACAACATCATTAAGAAGGAGAGAGTAACCGGCAGAGGGTTGGACTGGAGCTGATCG 
V Y N I I K K E S N R Q R V G L E L I A  
CCTCCGAGAACTTTGCCAGCCGGGCTGTTCTGGAGGCCCTAGGCTCTTGCCTG~CAACA 
S E N F A S R A V L E A L G S C L N N K  
AGTACTCTGAGGGGTACCCAGGCCAGAGGTACTATGGTGGGACGGAATTCATCGATGAGC 
Y S E G Y P G Q R Y Y G G T E F I D E L  
TAGAGGTCCTCTGTCAGAAGCGAGCGCTGCAGGTCTATGGCCTGGACCCCGAGTGCTGGG 
E V L C Q K R A L Q V Y G L D P E C W G  
GGGTTAACGTCCAGCCTTACTCAGGCTCCCCAGC~TTTCGCAGTGTACACGGCCCTGG 
V N V Q P Y S G S P A N F A V Y T A L V  
TGGAGCCCCATGGCCGCATCATGGGCCTGGACCTGCCGGATGGGGGCCACCTGACCCATG 
E P H G R I M G L D L P D G G H L T H G  
GGTTCATGACTGATAAGRAGAAGATTTCTGCCACGTCCATCTTTTTTG~TCTATGCCTT 
F M T D K K K I S A T S I F F E S M P Y  
ACRAGGTGAATCCCGATACCGGCTACATCAACTACGACCAG~GGAGGAGAACGCCCGCC 
K V N P D T G Y I N Y D Q L E E N A R L  
TCTTCCACCCGAGGCTGATCATTGCAGGGGACTAGCTGCTACTCCCGG~CCTGGACTACG 
F H P R L I I A G T S C Y S R N L D Y A  
CTCGGCTGCGCAAGATCGCTGACGACAATGGGGCGTACCTCATGGCTGACATGGCACATA 
R L R K I A D D N G A Y L M A D M A H I  
TCAGCGGGCTGGTGGCGGCCGGCGTGGTGCCTTCCCCCTTCGAGCACTGCCACGTGGTGT 
S G L V A A G V V P S P F E H C H V V ?  
CCACCACCACCCACAAGACCCTGCGGGGCTGCCGCGCCGGCATGATCTTCTACAGG~GG 
T T T H K T L R G C R A G M I F Y R K G  
GAGTGCGCAGTGTGGACCCCAAGACAGGC~GAGACTCGCTAC~CCTGGAGTCGCTCA 
V R S V D P K T G K E T R Y N L E S L I  
TCAACTCTGCTGTGTTCCCAGGCCTGCAAGGGGGGACCTCAC~CCACGCCATTGCTGGGG 
N S A V F P G L Q G G P H N H A I A G V  
TCGCGGTTGCTCTGAAGCAGGCCATGACTCCGGAGTTCAGAGCCTACCAGCGCCAGGTTG 
A V A L K Q A M T P E F F P Y Q R Q V V  
TGGCCAACTGCAGGGCTCTGGCTGAGGCCTTGATGGGACTGGGCTACAGAGTGGTCACAG 
A N C R A L P E A L M G L G Y R V V T G  
GGGGTTCTGACAACCACTTGATCCTCGTGGACCTCCGCTCC~GGCACAGATGGCGGCA 
G S D N H L I L V D L R S K G T D G G R  
GGGCAGAGAAGGTGCTGGAAGCCTGCTCCATCGCCTGCAAC~GAATACCTGCCCAGGTG 
A E K V L E A C S I A C N K N T C P G D  
ACAAAAGCGCACTACGGCCCAGTGGCTTGCGCCTGGGGACCCCAGCACTGACCTCCCGAG 
K S A L R P S G L R L G T P A L T S R G  
GACTCTTGGAAGAAGATTTCCGAAAGGTTGCCCCAWCACAGAGGCATAGAGCTGA 
L L E E D F P K V A H F I H R G I E L T  
CCCTGCAGATCCAGGATGCTGTAGGAGTGAAGGCCACCCTGRAGGAGTTCATGGAGAAGC 
L Q I Q D A V G V K A T L K E F Y E X L  
TGGCAGGGGCCGAGGAGCACCAGCGGGCTGTGACAGCCCTCAGAGCAGAGGTGGAGAGCT 
A G A E E H Q R A V T A L R A E V E S F  
TCGCCACCCTATTCCCGCTGCCTGGCCTGCCTGGCTTCTAGA 
A T L F P L P G L P G F ’  
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Fig. 1. The nucleotide sequence of sheep liver cytosolic SHMT cDNA 
and derived amino acid sequence. The amino acid sequence underlined 
was confirmed by direct N-terminal sequencing of the purified recombi- 
nant SHMT. The residues indicated by ( 0 )  are diffirent from the reported 
sheep liver cytosolic SHMT [17]. 
1 -thio-P-D-galactopyronoside for various time periods (0 - 5 h) 
and analyzed on SDSPAGE. There was no further increase in 
the level of expression beyond 2 h of isopropyl-1 -thio-P-D-ga- 
lactopyronoside induction (data not shown). Densitometric scan- 
ning of the gel (Fig. 3) showed that 22% of the total cellular 
protein was due to the overexpression of SHMT. More than 90% 
of this protein was present in the soluble fraction. 
Purification and characterization of the recombinant SHMT. 
The specific activity of the recombinant protein in the crude 
extract was 0.6U (pmol . HCHO . min-’ . mg-’) compared 
with the value of 0.02 U in sheep liver a 0.03 U in E. coli cells 
[BL21(DE3) strain]. 
The recombinant enzyme was purified by ammonium sulfate 
fractionation, Cibacron Blue agarose chromatography and Seph- 
acryl S-200 gel filtration (Table 1 and Fig. 3). This procedure 
resulted in a 5.5-fold purification and 27 % recovery. The recom- 
binant enzyme eluted on a Sephacryl S-200 column at the same 
position as the native enzyme suggesting that it is a tetramer like 
the native SHMT (data not shown). The enzyme was found to 
be homogeneous on SDSPAGE (Fig. 3) and had a subunit mo- 
lecular mass of 53 kDa. The single band obtained was transfer- 
red onto a poly(viny1idene difluoride) membrane and the N-ter- 
minus was sequenced. The N-terminal sequence of the first 14 
amino acids, AAPVNKAPRDADLW was identical to the de- 
duced sheep cytosolic SHMT sequence (Fig. 1). The kinetic 
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Fig.2. The construction of PET-SHMT plasmid. The steps used to 
ligate the SHMT-encoding PCR-amplified fragment into the expression 
vector (pET-3C), yielding the PET-SHMT plasmid are shown (see Ex- 
perimental procedures for details). P,10, T7 promoter; T,, T7 termina- 
tor; Ap', ampicillin-resistance gene; Npb = NdeI. 
Table 1. Purification of the recombinant SHMT. For total activity 
1 U = 1 pmol HCHO produced in 1 min at 37°C. 
Purification Total Total Specific Yield Purifica- 
step protein activity activity tion 
mg U U/mg % -fold 
protein 
Crude extract 202 120 0.6 100 1 .o 
Ammonium 
sulfate 
fractionation 102 110 1.1 91.6 1.8 
Blue agarose 19 50 2.7 41.6 4.5 
Sephacryl S-200 10 32 3.20 26.7 5.4 
(25% -65%) 
characterization of recombinant SHMT revealed that the enzyme 
had a K,  of 1 mM for serine, 0.82 mM for H,-folate and a V,,, 
of 4.6 pmol HCHO . min-' . mg-' protein. 
The enzyme had an absorbance maximum at 423.5nm, a 
characteristic feature of pyridoxal-P present as an internal aldim- 
ine (Fig. 4). The bound pyridoxal-P could be removed by incu- 
bating the enzyme with D-alanine (200 mM) for 3 h at 37°C 
followed by dialysis to remove the pyridoxamine phosphate and 
pyruvate formed in the reaction. The apoenzyme had no 
spectrum in the visible region (Fig. 4) and was enzymically in- 
active. The apoenzyme could be reconstituted into the holoen- 
zyme by the addition of pyridoxal-P (100 pM) as evidenced by 
the absorption spectrum with a maximum at 423.5 nm (Fig. 4) 
and the regaining of enzyme activity. The specific activity of the 
reconstituted enzyme was 3.0 pmol . min-' . mg-' compared 
with the value of 3.2 pmol . min-' . mg-' of the enzyme before 
removal of the pyridoxal-P. 
- 30 
- 20 
-1 4 
Fig. 3. The purification of recombinant sheep cytosolic SHMT from 
E. coli. Lane 1, crude extract (35 pg); lane 2, 25-65% ammonium sul- 
fate fraction (17 pg); lane 3, Cibacron blue agarose eluant (6 pg); lane 
4, Sephacryl S-200 fraction (6 pg); lane 5, Sephacryl S-200 fraction 
(14 pg); M, molecular-mass markers (Pharmacia); markers used were 
phosphorylase b, bovine serum albumin, ovalbumin, carbonic anhydrase, 
soybean trypsin inhibitor and a-lactalbumin. 
350 400 450 503 550 
hvelength(nrn) 
Fig. 4. The visible absorption spectrum of recombinant SHMT. The 
visible absorption spectrum of holo (-), apo (---) and reconstitu- 
ted (---) SHMT. Protein (0.8 mg) was used for recording the spectrum. 
DISCUSSION 
Although extensive biochemical investigations on the mech- 
anism of action of mammalian SHMT have been carried out 
previously [33, 341, a major limitation for a further understand- 
ing of the structure/function relationship has been the non-avail- 
ability of an overexpressing clone of the eukaryotic SHMT. The 
results presented in this communication demonstrate the overex- 
pression of an eukaryotic SHMT (from sheep liver) in E. coli. 
An SHMT overexpression vector (PET-SHMT) was constructed 
in which the sheep liver cytosolic SHMT encoding cDNA frag- 
ment was placed under the control of a strong T7 promoter, 
inducible by isopropyl-1-thio-p-D-galactopyranoside. The en- 
zyme was not only expressed at high levels, i.e., 20-fold above 
the basal level in E. coli but was also present predominantly in 
the soluble fraction (Fig. 3). This protein constituted 22 % of the 
total protein in the cell extracts. In contrast, the expression of 
rabbit liver cytosolic SHMT in COS-1 cells was only marginally 
above the basal level [lo]. 
The recombinant enzyme was purified to homogeneity with 
a yield of 10 mg/l bacterial culture (Table 1). The native and 
subunit molecular mass of the recombinant enzyme was 
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213 kDa and 53 kDa, respectively. Thus the recombinant SHMT 
is also a homotetramer like the cytosolic sheep SHMT [26]. 
However the recombinant enzyme from E. coli was shown to be 
a dimer [35, 361, whereas, the wild-type enzyme was a tetramer 
[37]. It would be interesting to examine the differences in the 
nature of subunit interactions that lead to different states of as- 
sembly of subunits in the E. coli and sheep liver recombinant 
enzymes. The N-terminal sequence of the recombinant enzyme 
was identical to the deduced sequence although, the N-terminal 
methionine was lacking. This is not surprising if we consider 
that the N-terminal methionine in the recombinant SHMT is fol- 
lowed by alanine. It has been observed that in  96% of the cyto- 
solic E. coli proteins, in which the second residue was alanine, 
the N-terminal methionine was excised [38]. A comparison of 
the deduced amino acid sequence of sheep cytosolic SHMT 
clone with the primary structure of the sheep liver cytosolic 
SHMT [17] revealed that there were differences in the amino 
acid sequence at 10 positions as indicated in Fig. 1. Those differ- 
ences might be attributable to the differences in the genetic vari- 
ety of sheep used for preparing cDNA library and for the isola- 
tion of the enzyme. In addition a few residues (A3/T, P4/A, 
WlllIF, V115/Y, G136/A, P171lA and R196/K were misiden- 
tified in the protein sequence and have now been corrected. De- 
spite small sequence differences between the enzyme purified 
from sheep liver and the recombinant enzyme, we did not detect 
any differences in the properties of the two enzyme preparations. 
The expressed SHMT effectively interacted with antibodies 
raised against sheep liver cytosolic SHMT indicating that the 
antigenic epitopes are well retained in the recombinant enzyme 
(data not shown) The enzyme was capable of using serine or p- 
phenylserine as the substrate, demonstrating its ability to carry 
out H,-folate-dependent or independent reaction. The predicted 
secondary structure of the recombinant enzyme was identical to 
that of the native enzyme (data not shown). The purified recom- 
binant enzyme had the characteristic visible absorption spectrum 
indicative of the presence of pyridoxal-P as an internal aldimine 
which could be removed and reconstituted in a manner similar 
to that of native sheep liver SHMT. The only difference in the 
properties of the recombinant enzyme and the native enzyme is 
the ability to bind CM-Sephadex which could have arisen from 
the absence of acetylation at the N-terminus or replacement of 
a few charged residues. The amino acid residues essential for 
activity are unchanged in the recombinant protein [7, 171. The 
results presented in this study convincingly demonstrated that 
the recombinant SHMT was functionally identical to the native 
enzyme. The availability of a homogeneous and active recombi- 
nant SHMT in abundant amounts has laid the foundation for 
critical studies aimed at elucidating the role of the amino acid 
residues involved in the catalysis and binding of the substrates 
and substrate analogues. 
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